Cargando…
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497351/ https://www.ncbi.nlm.nih.gov/pubmed/28676101 http://dx.doi.org/10.1186/s13054-017-1734-x |
| _version_ | 1783248142388428800 |
|---|---|
| author | Besnier, Emmanuel Brakenhielm, Ebba Richard, Vincent Tamion, Fabienne |
| author_facet | Besnier, Emmanuel Brakenhielm, Ebba Richard, Vincent Tamion, Fabienne |
| author_sort | Besnier, Emmanuel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5497351 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54973512017-07-07 Does anti-VEGF bevacizumab improve survival in experimental sepsis? Besnier, Emmanuel Brakenhielm, Ebba Richard, Vincent Tamion, Fabienne Crit Care Letter BioMed Central 2017-07-05 /pmc/articles/PMC5497351/ /pubmed/28676101 http://dx.doi.org/10.1186/s13054-017-1734-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Besnier, Emmanuel Brakenhielm, Ebba Richard, Vincent Tamion, Fabienne Does anti-VEGF bevacizumab improve survival in experimental sepsis? |
| title | Does anti-VEGF bevacizumab improve survival in experimental sepsis? |
| title_full | Does anti-VEGF bevacizumab improve survival in experimental sepsis? |
| title_fullStr | Does anti-VEGF bevacizumab improve survival in experimental sepsis? |
| title_full_unstemmed | Does anti-VEGF bevacizumab improve survival in experimental sepsis? |
| title_short | Does anti-VEGF bevacizumab improve survival in experimental sepsis? |
| title_sort | does anti-vegf bevacizumab improve survival in experimental sepsis? |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497351/ https://www.ncbi.nlm.nih.gov/pubmed/28676101 http://dx.doi.org/10.1186/s13054-017-1734-x |
| work_keys_str_mv | AT besnieremmanuel doesantivegfbevacizumabimprovesurvivalinexperimentalsepsis AT brakenhielmebba doesantivegfbevacizumabimprovesurvivalinexperimentalsepsis AT richardvincent doesantivegfbevacizumabimprovesurvivalinexperimentalsepsis AT tamionfabienne doesantivegfbevacizumabimprovesurvivalinexperimentalsepsis |